McDermott Advises Advanced Life Solutions on its Series A Fundraising with Two Family Holdings - McDermott Will & Emery

McDermott Advises Advanced Life Solutions on its Series A Fundraising with Two Family Holdings

Overview


McDermott Will & Emery advised Advanced Life Solutions, a company specializing in organ preservation for transplantation, on its Series A financing round with two family-owned holding companies, Pharmanet and Cantrak.

The proceeds of the fundraising will be used to finance the company’s CE Mark and FDA approval of its most advanced product, Perla®.

The McDermott team that advised Advanced Life Solutions comprised:

  • Henri Pieyre de Mandiargues, partner, and Louis Feuillée, associate

About McDermott


McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.